Similar articles

• Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.

  Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S; Norwegian Lung Cancer Study Group. Sundstrøm S, et al. J Clin Oncol. 2002 Dec 15;20(24):4665-72. doi: 10.1200/JCO.2002.12.111. J Clin Oncol. 2002. PMID: 12488411 Clinical Trial.
• Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary report.

  Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JL, Coles DT, Lee RE. Frytak S, et al. Am J Clin Oncol. 1987 Feb;10(1):33-5. doi: 10.1097/00000421-198702000-00007. Am J Clin Oncol. 1987. PMID: 3030092
• Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

  Einhorn LH, Crawford J, Birch R, Omura G, Johnson DH, Greco FA. Einhorn LH, et al. J Clin Oncol. 1988 Mar;6(3):451-6. doi: 10.1200/JCO.1988.6.3.451. J Clin Oncol. 1988. PMID: 2832549 Clinical Trial.
• [Recent progress in the treatment of ED small cell lung cancer].

  Nokihara H, Ohe Y. Nokihara H, et al. Nihon Rinsho. 2002 May;60 Suppl 5:480-4. Nihon Rinsho. 2002. PMID: 12101718 Review. Japanese. No abstract available.
• [Chemotherapy of small cell lung cancer].

  Komiya T, Takada M. Komiya T, et al. Gan To Kagaku Ryoho. 1996 Aug;23(9):1116-23. Gan To Kagaku Ryoho. 1996. PMID: 8751797 Review. Japanese.